Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven G Deeks

Showing results (611-620 of 663) with videos related to

Pageof 67
Sort By:
The Lancet. Microbe|January 12, 2026
SARS-CoV-2 infectious shedding and rebound among adults with and without oral antiviral use: two case-ascertained prospective household studiesMelisa M Shah, Glen R Abedi, Scott Lu, et al.
JCI Insight|March 10, 2025
Circulating neutralizing antibodies and SARS-CoV-2 variant replication following postvaccination infectionsMiguel A Garcia-Knight, J Daniel Kelly, Scott Lu, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 29, 2019
Combined HIV-1 sequence and integration site analysis informs viral dynamics and allows reconstruction of replicating viral ancestorsSean C Patro, Leah D Brandt, Michael J Bale, et al.
International Journal of Epidemiology|April 11, 2015
CD41 T cell recovery during suppression of HIV replication: an international comparison of the immunological efficacy of antiretroviral therapy in North America, Asia and AfricaElvin H Geng, Torsten B Neilands, Rodolphe Thièbaut, et al.
Nature Medicine|October 3, 2017
Defining total-body AIDS-virus burden with implications for curative strategiesJacob D Estes, Cissy Kityo, Francis Ssali, et al.
AIDS Research and Therapy|December 17, 2010
CD4 count at presentation for HIV care in the United States and Canada: are those over 50 years more likely to have a delayed presentation?Keri N Althoff, Kelly A Gebo, Stephen J Gange, et al.
Journal of Virology|February 4, 2021
Evaluating a New Class of AKT/mTOR Activators for HIV Latency Reversing Activity <i>Ex Vivo and In Vivo</i>Andrea Gramatica, Roland Schwarzer, William Brantley, et al.
Nature Reviews. Immunology|July 21, 2012
Towards an HIV cure: a global scientific strategy, Steven G Deeks, Brigitte Autran, et al.
The Journal of Infectious Diseases|August 8, 2018
The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical StudiesGolnaz Namazi, Jesse M Fajnzylber, Evgenia Aga, et al.
Nature|August 28, 2020
Distinct viral reservoirs in individuals with spontaneous control of HIV-1Chenyang Jiang, Xiaodong Lian, Ce Gao, et al.
Pageof 67

Showing results (611-620 of 663) with videos related to

Sort By:
Pageof 67
The Lancet. Microbe|January 12, 2026
SARS-CoV-2 infectious shedding and rebound among adults with and without oral antiviral use: two case-ascertained prospective household studiesMelisa M Shah, Glen R Abedi, Scott Lu, et al.
JCI Insight|March 10, 2025
Circulating neutralizing antibodies and SARS-CoV-2 variant replication following postvaccination infectionsMiguel A Garcia-Knight, J Daniel Kelly, Scott Lu, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 29, 2019
Combined HIV-1 sequence and integration site analysis informs viral dynamics and allows reconstruction of replicating viral ancestorsSean C Patro, Leah D Brandt, Michael J Bale, et al.
International Journal of Epidemiology|April 11, 2015
CD41 T cell recovery during suppression of HIV replication: an international comparison of the immunological efficacy of antiretroviral therapy in North America, Asia and AfricaElvin H Geng, Torsten B Neilands, Rodolphe Thièbaut, et al.
Nature Medicine|October 3, 2017
Defining total-body AIDS-virus burden with implications for curative strategiesJacob D Estes, Cissy Kityo, Francis Ssali, et al.
AIDS Research and Therapy|December 17, 2010
CD4 count at presentation for HIV care in the United States and Canada: are those over 50 years more likely to have a delayed presentation?Keri N Althoff, Kelly A Gebo, Stephen J Gange, et al.
Journal of Virology|February 4, 2021
Evaluating a New Class of AKT/mTOR Activators for HIV Latency Reversing Activity <i>Ex Vivo and In Vivo</i>Andrea Gramatica, Roland Schwarzer, William Brantley, et al.
Nature Reviews. Immunology|July 21, 2012
Towards an HIV cure: a global scientific strategy, Steven G Deeks, Brigitte Autran, et al.
The Journal of Infectious Diseases|August 8, 2018
The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical StudiesGolnaz Namazi, Jesse M Fajnzylber, Evgenia Aga, et al.
Nature|August 28, 2020
Distinct viral reservoirs in individuals with spontaneous control of HIV-1Chenyang Jiang, Xiaodong Lian, Ce Gao, et al.
Pageof 67